EP1309322 - USE OF 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF RETINAL DISORDERS [Right-click to bookmark this link] | |||
Former [2003/20] | METHOD OF TREATING NEURODEGENERATIVE DISORDERS OF THE RETINA AND OPTIC NERVE HEAD | ||
[2006/03] | Status | No opposition filed within time limit Status updated on 27.04.2007 Database last updated on 13.11.2024 | Most recent event Tooltip | 25.07.2008 | Change - representative | published on 27.08.2008 [2008/35] | Applicant(s) | For all designated states Alcon, Inc. Bösch 69 6331 Hünenberg / CH | [2006/02] |
Former [2003/20] | For all designated states Alcon, Inc Bosch 69, P.O. Box 62 6331 Hünenberg / CH | Inventor(s) | 01 /
GAMACHE, Daniel, A. 5610 Hunterwood Lane Arlington, TX 76017 / US | 02 /
GRAFF, Gustav 6500 County Road 809 Cleburne, TX 76031 / US | 03 /
YANNI, John, M. 2821 Donnybrook Drive Burleson, TX 76028 / US | 04 /
KAPIN, Michael, A. 3602 Silkwood Trail Arlington, TX 76016 / US | [2003/20] | Representative(s) | Hanna, Peter William Derek, et al Hanna Moore + Curley Garryard House 25/26 Earlsfort Terrace Dublin 2, D02 PX51 / IE | [N/P] |
Former [2008/35] | Hanna, Peter William Derek, et al Hanna Moore & Curley 13 Lower Lad Lane Dublin 2 / IE | ||
Former [2003/33] | Hanna, Peter William Derek, et al Hanna, Moore & Curley, 11 Mespil Road Dublin 4 / IE | ||
Former [2003/20] | Hanna, Peter William Derek Peter Hanna Associates 11 Mespil Road Dublin 4 / IE | Application number, filing date | 01959734.3 | 13.08.2001 | [2003/20] | WO2001US25319 | Priority number, date | US20000225132P | 14.08.2000 Original published format: US 225132 P | [2003/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0213805 | Date: | 21.02.2002 | Language: | EN | [2002/08] | Type: | A2 Application without search report | No.: | EP1309322 | Date: | 14.05.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.02.2002 takes the place of the publication of the European patent application. | [2003/20] | Type: | B1 Patent specification | No.: | EP1309322 | Date: | 21.06.2006 | Language: | EN | [2006/25] | Search report(s) | International search report - published on: | EP | 30.05.2002 | Classification | IPC: | A61K31/215, A61K31/165, A61K31/185, A61P25/02, A61P27/02 | [2006/06] | CPC: |
A61K31/24 (EP,US);
A61K31/165 (EP,US);
A61K31/195 (EP,US);
A61K31/196 (EP,US);
A61P25/02 (EP);
A61P27/02 (EP);
|
Former IPC [2003/20] | A61K31/215, A61K31/165, A61K31/185, A61P9/00 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/20] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | VERWENDUNG VON 3-BEZOYLPHENYLESSIGSÄURE-DERIVATEN ZUR BEHANDLUNG VON NETZHAUTERKRANKUNGEN | [2006/03] | English: | USE OF 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF RETINAL DISORDERS | [2006/03] | French: | UTILISATION THERAPEUTIQUE DE DERIVES D'ACIDE 3-BENZOYLPHENYLACETIQUE POUR TRAITER LES AFFECTIONS DE LA RETINE | [2006/03] |
Former [2003/20] | VERFAHREN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN DER RETINA ODER DER SEHNERVENENDUNG | ||
Former [2003/20] | METHOD OF TREATING NEURODEGENERATIVE DISORDERS OF THE RETINA AND OPTIC NERVE HEAD | ||
Former [2003/20] | PROCEDE POUR TRAITER DES TROUBLES NEURODEGENERATIFS DE LA RETINE ET DE LA PAPILLE OPTIQUE | Entry into regional phase | 07.02.2003 | National basic fee paid | 07.02.2003 | Designation fee(s) paid | 07.02.2003 | Examination fee paid | Examination procedure | 04.03.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 07.02.2003 | Amendment by applicant (claims and/or description) | 07.02.2003 | Examination requested [2003/20] | 18.03.2004 | Despatch of a communication from the examining division (Time limit: M04) | 09.07.2004 | Reply to a communication from the examining division | 13.10.2005 | Despatch of a communication from the examining division (Time limit: M02) | 23.11.2005 | Reply to a communication from the examining division | 25.01.2006 | Communication of intention to grant the patent | 02.05.2006 | Fee for grant paid | 02.05.2006 | Fee for publishing/printing paid | Opposition(s) | 22.03.2007 | No opposition filed within time limit [2007/22] | Fees paid | Renewal fee | 25.08.2003 | Renewal fee patent year 03 | 23.08.2004 | Renewal fee patent year 04 | 19.08.2005 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2007/45] |
Former [2007/36] | IT | 21.06.2006 | Cited in | International search | [DA]US4045576 (WELSTEAD JR WILLIAM J, et al); | [DA]US4254146 (WALSH DAVID A); | [DA]GB2071086 (ROBINS CO INC A H); | [DA]US4313949 (SHANKLIN JR JAMES R, et al); | [A]DE3026402 (SYNTEX CORP [US]); | [DA]GB2093027 (ROBINS CO INC A H); | [DA]US4503073 (WALSH DAVID A [US], et al); | [DA]US4568695 (MORAN HENRY W [US], et al); | [DA]US4683242 (POSER RICHARD G [US]); | [DA]EP0326915 (SENJU PHARMA CO [JP], et al); | [DA]US5475034 (YANNI JOHN M [US], et al); | [A]US5811446 (THOMAS PETER G [US]); | [DX]US6066671 (YANNI JOHN M [US], et al) [DX] 1-12 * claims 1,2 *; | [PX]WO0128474 (ALCON UNIVERSAL LTD [CH], et al) [PX] 1-12 * page 1, line 1 - page 2, line 14; claims 1-35 *; | [E]US6342524 (HELLBERG MARK R [US], et al) [E] 1-12 * claims 1-6 * |